Displaying items by tag: alabama vaccine research clinic

A groundbreaking clinical research trial at UAB’s Alabama Vaccine Research Clinic to compare injectable PrEP versus a daily oral regimen for HIV prevention is now recruiting participants. 
Antibody VRC01 proves safe for individuals infected with HIV-1 but only modestly controls the virus in participants who stop receiving antiretroviral therapy.